Back

Results - Announcements

Sales rise 53.39% to Rs 175.19 crore

Senores Pharmaceuticals consolidated net profit rises 77.29% in the March 2026 quarter

15-May-2026, 07:34
Net profit of Senores Pharmaceuticals rose 77.29% to Rs 31.61 crore in the quarter ended March 2026 as against Rs 17.83 crore during the previous quarter ended March 2025. Sales rose 53.39% to Rs 175.19 crore in the quarter ended March 2026 as against Rs 114.21 crore during the previous quarter ended March 2025.

For the full year,net profit rose 96.99% to Rs 115.36 crore in the year ended March 2026 as against Rs 58.56 crore during the previous year ended March 2025. Sales rose 58.85% to Rs 632.63 crore in the year ended March 2026 as against Rs 398.25 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	175.19	114.21	53	632.63	398.25	59
OPM %	27.11	17.02	-	26.61	22.52	-
PBDT	56.70	25.91	119	190.35	87.41	118
PBT	47.40	20.68	129	159.10	70.57	125
NP	31.61	17.83	77	115.36	58.56	97